Protein kinase C inhibits adenylyl cyclase type VI activity during desensitization of the A2a-adenosine

H L Lai1, T H Yang, R O Messing

  • 1Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.

Insights

Protein kinase C (PKC) inhibits adenylyl cyclase type VI (AC6) activity during A2a adenosine receptor desensitization. This calcium-independent PKC regulation fine-tunes cAMP synthesis in PC12 cells.

Area of Science:

  • Cellular signaling
  • Molecular pharmacology
  • Neuroscience

Background:

  • Adenylyl cyclase type VI (AC6) activity is suppressed during A2a adenosine receptor desensitization in PC12 cells.
  • Previous studies suggested phosphorylation mediates this suppression.

Purpose of the Study:

  • To identify the kinase responsible for AC6 phosphorylation and inhibition during A2a desensitization.
  • To elucidate the role of protein kinase C (PKC) in regulating AC6 activity.

Main Methods:

  • Inhibition of PKC using multiple methods.
  • Direct phosphorylation and inhibition assays using purified PKC and recombinant AC6.
  • Overexpression of PKC isoforms (PKCdelta, PKCepsilon) in PC12 cells.
  • Measurement of Ca2+-independent PKC activity.

Main Results:

  • PKC inhibition blocked AC6 suppression during A2a desensitization.
  • Purified PKC directly phosphorylated and inhibited AC6.
  • Overexpression of PKC isoforms reduced AC6 activity.
  • A2a receptor stimulation increased Ca2+-independent PKC activity.

Conclusions:

  • A calcium-independent PKC isoform is responsible for inhibiting AC6 activity during A2a desensitization in PC12 cells.
  • This pathway represents a novel mechanism for regulating cAMP synthesis.
  • Independent regulation by PKC and Ca2+ allows fine-tuning of signaling pathways.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Desensitization and Tachyphylaxis01:20

Desensitization and Tachyphylaxis

Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...